“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|'Napsterizing' Pharmaceuticals: Access, Innovation, and Consumer Welfare In an All-Generic World|
James W. Hughes, Michael J. Moore, Edward A. Snyder; working paper published by National Bureau of Economic Research
Oct. 1, 2002
Excerpt: We analyze the effects on consumers of an extreme policy experiment-- 'Napsterizing' pharmaceuticals-- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs ... [P]roviding greater access to the current stock of prescription drugs yields large benefits to existing consumers. However, realizing those benefits has a substantially greater cost in terms of lost consumer benefits from reductions in the flow of new drugs.
|Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).|
|An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).|